Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
Clinical trial NCT06561022 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06561022
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-21
- Primary completion
- 2025-12-31
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.